ARID1A and ovarian endometrioid carcinoma: It is reported that a nonsense or indel mutation of ARID1A was correlated with loss or reduction of protein expression in uterine endometrioid carcinoma, ovarian endometrioid carcinoma and clear cell carcinoma [11]–[13], [18].